In his latest Law360 article, Consultant Kiefer Ahn explores pharmaceutical patent applications identified with artificial intelligence components by the US Patent and Trademark Office (USPTO). “Looking for Patterns in Pharmaceuticals’ Use of AI Patents” discusses the USPTO’s development of the AI Patent Dataset (AIPD) to assist in identifying AI components in patents. Dr. Ahn highlights patterns that emerge in pharmaceutical patents that USPTO data indicate have AI components. The article emphasizes the potential importance of these patterns given the current attention surrounding AI technologies while cautioning that the USPTO’s identifications were also produced via machine learning.